- Home
- UEIC vs BYSI Comparison
UEIC vs BYSI Comparison
Compare UEIC & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- BYSI
- Stock Information
- Founded
- UEIC 1986
- BYSI 2010
- Country
- UEIC United States
- BYSI United States
- Employees
- UEIC N/A
- BYSI N/A
- Industry
- UEIC Consumer Electronics/Appliances
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- BYSI Health Care
- Exchange
- UEIC Nasdaq
- BYSI Nasdaq
- Market Cap
- UEIC 79.4M
- BYSI 72.1M
- IPO Year
- UEIC 1993
- BYSI 2017
- Fundamental
- Price
- UEIC $4.98
- BYSI $1.31
- Analyst Decision
- UEIC Strong Buy
- BYSI
- Analyst Count
- UEIC 2
- BYSI 0
- Target Price
- UEIC $14.50
- BYSI N/A
- AVG Volume (30 Days)
- UEIC 100.7K
- BYSI 24.5K
- Earning Date
- UEIC 05-01-2025
- BYSI 01-01-0001
- Dividend Yield
- UEIC N/A
- BYSI N/A
- EPS Growth
- UEIC N/A
- BYSI N/A
- EPS
- UEIC N/A
- BYSI N/A
- Revenue
- UEIC $394,879,000.00
- BYSI N/A
- Revenue This Year
- UEIC $4.73
- BYSI N/A
- Revenue Next Year
- UEIC $4.56
- BYSI N/A
- P/E Ratio
- UEIC N/A
- BYSI N/A
- Revenue Growth
- UEIC N/A
- BYSI N/A
- 52 Week Low
- UEIC $4.51
- BYSI $0.98
- 52 Week High
- UEIC $14.20
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- UEIC 31.32
- BYSI 44.17
- Support Level
- UEIC $4.88
- BYSI $1.03
- Resistance Level
- UEIC $5.44
- BYSI $1.27
- Average True Range (ATR)
- UEIC 0.52
- BYSI 0.15
- MACD
- UEIC 0.03
- BYSI 0.00
- Stochastic Oscillator
- UEIC 23.15
- BYSI 48.53
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.